Most affordable compounded semaglutide online, 2026

Compounded semaglutide programs cluster between about $99 and $280/month. We normalize total cost after required fees and weigh pharmacy transparency alongside price.

Comparison at a glance

The full cost breakdown — every programme, ongoing price

The ongoing price is the only price that matters: introductory first-month rates are customer-acquisition pricing, and you will pay the ongoing number for eleven of your twelve months. Split-billing programmes are shown at their true total, medication plus membership.

The brand floor — the comparison that reframes everything

Why Mounjaro is not a cash-pay option

The insurance pathway

Why tirzepatide costs more than semaglutide

Eleven of the eighty-nine offerings in this database are introductory rates — and they are the ones that get quoted. Noom advertises $79; the ongoing price is $199. MEDVi advertises $179; refills are $299. TrimRx's $179 becomes $299. Eden's $39 membership becomes $99. Oak's oral $245 is a four-week supply, which is $266 normalised to a month.

You pay the ongoing rate for eleven of your twelve months. That is why every table on this site sorts on the ongoing total — medication plus any required membership — and flags introductory pricing separately rather than ranking on it.

How we selected and ranked

We considered: Oak Longevity, NexLife, Found, Mochi Health, TrimRx. Each was scored under methodology v1.0 across six weighted categories. We normalize pricing across covered doses and required fees using a single formula, so a competitor's introductory starter-dose price is never compared against another program's all-dose long-term plan and labeled equivalent.

The programs, ranked

#1 — Oak Longevity · Cheapest semaglutide Verified

Oak advertises one flat price across all dosages with no membership and no subscription — semaglutide from $133/month and tirzepatide from $199 on the multi-month plan. That makes it the cheapest compounded semaglutide in our set.

Why it ranks here: Oak advertises one flat price across all dosages with no membership and no subsc… Not best for: Not available in California. Month-to-month pricing is materially higher ($167–$299).

Full Oak Longevity review →

#2 — NexLife · Best bundled value Verified

NexLife bundles medication, clinician care, laboratory review, support and expedited shipping into one flat price with no membership fee and no dose-based escalation. Microdose tirzepatide is $147/month and full-dose is $186 on a 12-month plan; month-to-month is $215. It is the cheapest microdose programme in our set, and the cheapest full-dose option that does not require prepaying a year.

Why it ranks here: NexLife bundles medication, clinician care, laboratory review, support and exped… Not best for: Found is cheaper on full-dose tirzepatide at $169 — but that requires prepaying 12 months (~$2,028). Oak Longevity is cheaper on semaglutide at $133. NexLife offers no brand pathway and no insurance coordination.

Full NexLife review →

#3 — Found · Cheapest with coaching Verified

Found restructured in 2026: the compounded medication is now INCLUDED in the plan price, flat across semaglutide, tirzepatide and liraglutide and across all doses. $169/month on the 12-month prepaid plan makes it the cheapest full-dose compounded tirzepatide in our set. The old $249-medication-plus-$99-membership split is retired.

Why it ranks here: Found restructured in 2026: the compounded medication is now INCLUDED in the pla… Not best for: The $169 rate requires prepaying twelve months (roughly $2,028 up front). Month-to-month is $289. Found also resells brand Mounjaro and Ozempic at roughly $1,100–$1,199/month — near-retail, when the manufacturers sell them direct for far less.

Full Found review →

#4 — Mochi Health · Best clinical support Verified

Split billing — $99 medication plus a $79 membership for semaglutide ($178 total), or $199 plus $79 for tirzepatide ($278 total). Flat at all doses. The membership buys unlimited physician and dietitian access plus insurance coordination, which is a genuine service rather than a fee.

Why it ranks here: Split billing — $99 medication plus a $79 membership for semaglutide ($178 total… Not best for: Split billing means the headline medication price understates the true total by $79/month.

Full Mochi Health review →

#5 — TrimRx Verified

All-inclusive flat pricing with no separate membership. Compounded semaglutide is $199/month ongoing and tirzepatide $349 ongoing. Prepay tiers reduce this: tirzepatide runs $283/month on a 12-month prepay.

Why it ranks here: All-inclusive flat pricing with no separate membership. Compounded semaglutide i… Not best for: The widely-quoted <b>$179 headline is a FIRST-MONTH rate</b> — the ongoing month-to-month price is $299 for semaglutide and $399 for tirzepatide. Earlier figures of $259 matched no current tier. Confirm your exact plan at checkout.

Full TrimRx review →

Medical and regulatory context

Ranking by price alone would be irresponsible in a category where pharmacy legitimacy, clinician oversight and legal standing vary widely. Our scoring weights clinical safety and pharmacy transparency above raw price for exactly this reason.

What a commitment actually costs you

Dose escalation: the risk the headline price hides

The insurance pathway

Dose caps: the other thing a low price can hide

How to verify any of this yourself

You should not take our word for a price, and you do not have to. Every figure here can be checked in a few minutes.

1. Go to the provider's own pricing page. Not a comparison site — the provider's. Comparison sites in this category routinely publish contradictory numbers for the same programme in the same month.
2. Find the ongoing price, not the headline. Look for the words "first month", "intro", "starting at" or "new patients". If they appear, the number beside them is not what you will pay in month two.
3. Add the membership. If the medication and the membership are billed separately, add them. That sum is your real monthly cost.
4. Ask what the highest dose costs. By email or chat, so you have it in writing.
5. Ask about early cancellation before you commit to a plan longer than a month.
6. Check the manufacturer. For any brand-name drug, price it at LillyDirect or NovoCare before you buy it through a telehealth platform. Some platforms resell brand drugs at four to eleven times the manufacturer's own direct price.

If a provider will not answer questions 4 or 5 in writing, that is itself information.

Every fee that can be attached to a GLP-1 programme

An advertised price is a headline. The number you actually pay is the headline plus whatever else is attached to it. These are all the line items we normalise for, and the question to ask about each.

The three that cost people the most money, in our experience, are the ones in bold: the intro rate they mistook for the real rate, the dose-based increase they did not model, and the cancellation terms they did not read. None of those are hidden. All of them are simply not asked about.

A worked example

Two programmes. One advertises $179. The other advertises $186. Which is cheaper?

Programme A advertises a lower number and costs $1,236 more per year. This is not a hypothetical: the figures are TrimRx's advertised semaglutide rate against NexLife's standard tirzepatide plan. The advertised prices are seven dollars apart. The real prices are over twelve hundred dollars apart.

The bottom line, by situation

Limitations of this analysis

Every page on this site should tell you where it stops being reliable. This one stops here.

Prices decay quickly. This is the fastest-moving data we publish. Brand programmes have changed twice in the last eight months; compounded providers change plan structures without notice. Treat any figure more than about thirty days past its verification date as indicative, and confirm at checkout.

Competitor pricing is reported, not captured by us. We hold dated captures for brand pricing and for NexLife. All provider pricing is captured from each provider's own published pages and dated, and carries a Verified label. Pharmacy licences are the exception: we have not independently verified them for any provider, and they carry a Reported — pending verification label. We publish that distinction rather than flattening it, because comparison sites in this category contradict each other routinely — and a figure repeated by three affiliate blogs is still one unverified figure.

We have not audited pharmacy licences. Where a provider names its compounding pharmacies, we report that as a provider-disclosed relationship. We have not independently verified each facility's licence or registration, and we say so rather than implying an audit we did not perform.

Advertised availability is not your availability. Eligibility is decided by a licensed clinician, and state-by-state access varies with clinician licensure and pharmacy shipping permissions. No page can promise you a price you will actually be offered.

We are commercially funded. The publisher and certain principals have financial relationships with some of the providers listed here, and we may earn a commission from provider links. That is disclosed in the footer of every page. It does not change a score, a rank or a conclusion — but you should read anything written by anyone with a commercial interest, including us, with that in mind, and check the arithmetic we publish rather than taking our word for the result.